OmniBRx Biotechnologies raises Rs.30-Cr from SIDBI VC

Ahmedabad-based Bioprocess engineering company OmniBRx Biotechnologies received INR 30 crore in a Series A funding round from SIDBI VC. Indus Capital was the sole financial advisor to OmniBRx for this deal. The company is looking to expand its business in the international markets, besides investing in capacity addition and building manufacturing facilities. The CellBRx Single-use Bioreactors from OmniBRx claims to be the world's largest and most efficient vaccine manufacturing platform for large-scale vaccines and viral vector production. OmniBRx has also developed an integrated seed train development platform in close-loop sequentially programmed bioreactor systems.